Back to top
Through a strategic partnership with the Livermore Lab Foundation, the Laboratory is applying its wide-ranging capabilities to study amyotrophic lateral sclerosis. Read more in this issue of Science & Technology Review (S&TR): https://str.llnl.gov/2022-10/fischer.